chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pronounced exacerbation of benign positional vertigo, such that turning "my" head rapidly (even when seated or laying down)  will trigger 30 seconds-1 minute of severe dizziness and related nausea.; Pronounced exacerbation of benign positional vertigo after 2nd dose, such that turning "my" head rapidly (even when seated or laying down) will trigger 30 seconds-1 minute of severe dizziness and related nausea.; Pronounced exacerbation of benign positional vertigo after 2nd dose, such that turning "my" head rapidly (even when seated or laying down) will trigger 30 seconds-1 minute of severe dizziness and related nausea.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW1072) via an unspecified route of administration in the left arm on 21Apr2021 at 14:15(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included ehlers-danlos, hashimoto's thyroiditis, reynaud's, chronic migraines, attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), depression, varicose veins, post-nasal drip, intermittent flare-ups of perioral and periorbital dermatitis, repeated cervical and lumbar spinal injuries, "frayed" R anterior cruciate ligament (ACL), allergies to gluten, casein, dust mite feces and sulfa-based antibiotics are completely ineffective. Prior to vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The concomitant medications included atomoxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and unspecified medication of 100 mg, all from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 20Mar2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 09:30, after 2nd dose, the patient experienced pronounced exacerbation of benign positional vertigo, such that turning her head rapidly (even when seated or laying down) would trigger 30 seconds-1 minutes of severe dizziness and related nausea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pronounced exacerbation of benign positional vertigo, severe dizziness and related nausea were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Headache and chills at 3am 1/31; fever, chills, body aches and headache at 7am 1/31; another wave of chills, body aches, fever, and headache around 12pm 1/31
swollen eye/eyelid; swelling is from corner of nose to eye lid and underneath; sensitive to touch; super puffy; left eye was itching; This case was received via Regulatory Authority (Reference number: US-irms-MOD21-127474 ) on 06-Aug-2021 and was forwarded to Moderna on 06-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of EYE PRURITUS (left eye was itching), EYE SWELLING (swollen eye/eyelid), SWELLING OF EYELID (swelling is from corner of nose to eye lid and underneath), SENSITIVE SKIN (sensitive to touch) and PERIORBITAL SWELLING (super puffy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     It was reported that the patient had no medical history.  Concurrent medical conditions included Gluten sensitivity, Allergy (Allergic to hops), Dairy intolerance (Allergic to dairy products) and Drug allergy (Allergic to Wellbutrin). Concomitant products included THYROID (ARMOUR THYROID) for an unknown indication.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Aug-2021, the patient experienced EYE PRURITUS (left eye was itching). On 06-Aug-2021, the patient experienced EYE SWELLING (swollen eye/eyelid), SWELLING OF EYELID (swelling is from corner of nose to eye lid and underneath), SENSITIVE SKIN (sensitive to touch) and PERIORBITAL SWELLING (super puffy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N) (topical) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, EYE PRURITUS (left eye was itching) was resolving and EYE SWELLING (swollen eye/eyelid), SWELLING OF EYELID (swelling is from corner of nose to eye lid and underneath), SENSITIVE SKIN (sensitive to touch) and PERIORBITAL SWELLING (super puffy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported also include Eye drops.  Patient reports that around 2:45 AM on 05-Aug-2021, she woke up and her left eye was itching, thinking it was a mosquito bite.  The itching was followed by supper puffy swollen left eye/eye lid. patient describes the reaction sensitive to touch. The location of the swelling is from corner of the nose to eye lid and underneath.  Patient used pain medications and Benadryl topical product to alleviate the symptoms and patient states that medication did help with the itching but not swelling.
No adverse reaction; after admin, this LPN realized vaccination had expiration date of 02-SEP-2020; route/site: IM Vastus Lateralis; This spontaneous report was received from a Licensed Practical Nurse, referring to a 5-year-old female patient. The patient's pertinent medical history, concurrent conditions and previous drug allergies or reactions were not reported. Concomitant therapies included diphtheria toxoid (+) pertussis acellular 3-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid(KINRIX) and sterile diluent (MERCK STERILE DILUENT).  On 09-SEP-2020, the patient was vaccinated with one dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD)  intramuscular in the left vastus lateralis (incorrect route of product administration) as prophylaxis (dosage regimen was not provided; lot number S006829 and expiration date 02-SEP-2020, which have been verified to be valid). After administration, the nurse realized vaccination had expiration date of 02-SEP-2020 (expired vaccine used). No adverse reactions after vaccination.
Patient and mother came in for second COVID vaccine, vaccine was given, pharmacist then realized the second dose was given 1 1/2 weeks early.
This spontaneous report as received from a registered nurse refers to a 17 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 18-SEP-2017, the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # N008823, expiry date: 26-MAY-2018) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA007014: US-009507513-1709USA000054.
Pt called on 06/08/2021 to inquire if she needs to take the 2nd dose since she had  Tingling of her whole arm after few minutes of the vaccine. She also recently started twitching her arms in last couple days. I referred her to consult with her doctor.
This spontaneous report as received from a certified medical assistant refers to numerous unspecified patients of unknown age. On numerous unspecified dates, numerous unspecified patiens were vaccinated with GARDASIL (dose, strength and frequency not provided). GARDASIL was improperly stored. This is one of several reports from the same source.
Within 15 minutes of receiving the Moderna vaccine, my lips started to tingle but no swelling occurred.  Within the hour, the middle of my right shoulder (near my clavicle) up the side of my neck became very tight.  The left side of my face, from the top of my cheek bone down to the corner of my lip, had a numb sensation with a feeling of electrical impulses going through it.  I alerted the County Health nurse on site who gave me the vaccine and she called her office and I called my regular physician.  I was told to take Benadryl.  The tingling in the lips went away, but I have experienced the same numbness/electrical impulse sensation on the left side of my face everyday since receiving the vaccine.  I reached out to the local Public Health last week and they advised me to contact my regular physician to let him know and to fill out the VAERS form.
Within a few hours of vaccine he was experiencing headache, earache, chills and flu like symptoms. He then had a fever and diarrhea. He missed school and also left early a couple days because of the diarrhea, chills, headache and pain at injection site. Put him on a BRAT diet until we noticed blood in his stool and salmon colored mucus along with a sleepless night on june 20th so we made an appointment for a doctor to make a house visit and discovered he has a ear infection along with the stomach problems. They gave him a 10 day antibiotic which only exacerbated the inflammation in his gut which caused an increase in the red stool and salmon colored mucus. He had 2 more visits and they are asking for a stool sample to see what is happening with his gut and may refer to a GI doctor if problem does not clear up. He still complains of on and off ear pain but the last visit on August 6th shows no infection but the pain still comes and goes.
FEVER, CHILLS, MUSCLE ACHE, JOINT PAIN AND SWELLING, SEVERE INFLAMATION AT INJECTION SITE, NAUSEA, BRAIN FOG. SEVERE REACTION LASTED 2 DAYS. 1 WEEK LATER I AM FEELING TIRED AND STILL HAVE BRAIN FOG
cough; colds; sick; This is a spontaneous report from a Regulatory Authority via a contactable consumer (patient).  A female patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date: Not reported), via an unspecified route of administration on 14Apr2021 as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient got sick with Cough and colds and was wondering if she could still go and get the 2nd dose of the vaccine upcoming on 05May2021. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
patient  started to experience some soreness in the left arm a couple hours after her immunizations,  She noted a fever up to 100.1 last night, using Tylenol, she is currently on an antibiotic for an infection in her foot, today her left arm is very sore and has redness. Doctor advised to use a topical cortisone cream to left upper arm. More pink the erythematous and no red streaks and no axillary lymphadenopathy per her office notes. We will check on patient tomorrow to f/u.
nauseated; Redness; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseated) and ERYTHEMA (Redness) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NAUSEA (nauseated) and ERYTHEMA (Redness). At the time of the report, NAUSEA (nauseated) and ERYTHEMA (Redness) outcome was unknown.            Concomitant medication was not provided by the reporter.  The treatment medication was unknown.   This case was linked to MOD-2021-034270 (Patient Link).
Fever of 100.2; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.2) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 100.2). At the time of the report, PYREXIA (Fever of 100.2) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) 100.2.         Concomitant medication include blood pressure medication.  Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Painful injection arm that is hard to lift above the head; Painful injection arm that is hard to lift above the head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful injection arm that is hard to lift above the head) and JOINT RANGE OF MOTION DECREASED (Painful injection arm that is hard to lift above the head) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033c21a and 048b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Jun-2021, the patient experienced PAIN IN EXTREMITY (Painful injection arm that is hard to lift above the head) and JOINT RANGE OF MOTION DECREASED (Painful injection arm that is hard to lift above the head). At the time of the report, PAIN IN EXTREMITY (Painful injection arm that is hard to lift above the head) and JOINT RANGE OF MOTION DECREASED (Painful injection arm that is hard to lift above the head) outcome was unknown.            Patient reported no known allergies and not taking any concomitant medication  Treatment information reported that patient not yet contacted his healthcare provider regarding the side effects and has not taken any medication to alleviate the pain
pt rcvd flu vax (1993-94 formula) on 20OCT93; treated w/Seldane for unk sx; admitted to ICU 06NOV93 w/dx of GBS;
This spontaneous report as received from health care worker refers to a child female patient of unknown age. The patient pertinent medical history was not reported. On 14-JAN-2010, the patient was vaccinated with VAQTA (dose and route were unknown). On 08-APR-2010 and 06-AUG-2014, the patient was vaccinated with HAVRIX. No adverse effects were reported. No product quality complaint (PQC) was reported for hepatitis a vaccine, inactivated. Additional information has been requested.
Injection site on left deltoid swollen, erythematous, and painful. By 6:18 PM the swelling, erythema, and pain had spread from shoulder to elbow. Patient was advised to keep elevated and apply cool compress overnight, if more ill appearing overnight should go to ER. Patient was seen by Dr. on 12/31/14 and noted the following: 'There is a patch of erythematous skin overlying the left deltoid area consistent with the injection site. There are a oule of adjacent flat slightly raised similar patches medial to the arm, on the shoulder of the same side. No distant eruption. Initially tender only'. Parent was instructed to continue oral BENADRYL as needed for itching and instructed to call the office if not continuing to improve. No further symptoms were reported by the parent after this.
Intense kidney pain. I could barely walk or sit. Lasted 10am-9pm the day after I got the 2nd dose of the vaccine. I also had diarrhea, stomach cramping, and joint pain in my knees but I think those are more common.
pain injection site on day of vaccine, rash, swelling and hot to touch injection site on Saturday morning Narrative:
Pt had shot 8 days ago. Today she woke up with a localized2x2 hive. Patient reports some itching, but denies pain or respiratory issues. She took a benadryl prior to coming to the clinic. She has never had this happen before. Pt advised to continue benadryl and cold compresses and NSAIDs if needed. Did not look concerning for cellulitis, however counseled pt on what signs/sx to look for and if it did progress to call PCP for possible antibiotics. Also ensured that pt was okay to receive second dose of moderna.
Patient received vaccine and 5 minutes after vaccine admin., she started with mouth and throat tingling, dizziness and headache.  Evaluated by EMS at the scene and the transported to UNC-Nash  Hospital to be evaluated.
Less than 24 hours, very, very sore arm.  Very bad headache, shivering.  Less than 48 hours later, diarrhea and sneezing.
The nurse had difficulty injecting the vaccine in my left arm and injected half of the vaccine. She changed needles and injected the other half of the vaccine in my right arm. Within two hours both shoulders started to hurt. The pain is mainly in the shoulder joints but can radiate down my upper arms and under both arms. The pain increases with certain shoulder movements but also occurs with no arm/shoulder movement. The pain is still present but has decreased from the first day after receiving the vaccine. I have received the flu vaccine for about 25 years without problems and received the high dose flue vaccine for the first time last year without problems.
A week after my first vaccine I started spotting (menstrual). My period has not started since. I have been spotting every other day. I spoke to a friend and she has the same issues.
Muscle weakness, muscle spasms, staggering, was unable to walk, strained abdomen, cold air caused knees and legs to ache, blood in urine, constant urination, no appetite.
Local site reaction on right arm, and then several days later developed Numbness and tingling in bilateral arms, and big toe. EMG confirmed diagnosis of Guillan Barre Syndrome.
Pt. stated he could not see after getting shot. Pt. states he felt dizzy and then asked son to drive approximately 5 seconds after the shot.
10 minutes after receiving the vaccine, nurses came over to check on me because I was flushed. I reported feeling light headed and dizzy to them. They checked my blood pressure and noticed it was high. I was told to sit in observation, drink water and eventually it came down on its own. Afterwards, I noticed I was late for my period by 2 weeks and when it came, it was normal at first. However, it continued for 2 weeks with progressive blood flow and clotting. By the end of the 2 weeks, the clotting was the size of "tangerines" and the blood flow was uncontrollable. I ended up in Urgent care who sent me to the ER when they noticed I was very tachycardic. In the ER, they ran lots of blood tests, did a pelvic ultrasound and a pregnancy test (to rule out ectopic pregnancy). I ended up having a procedure to remove some uterine tissue, and was prescribed progesterone for 10 days to stop bleeding. Once the 10 days were up, the bleeding resumed and I was put on a second round of progesterone. In the meantime I had a uterine tissue biopsy done, and followed up with an OBGYN. I underwent an endometrial ablation and a full D&C. After that, the bleeding symptoms resolved; however I still experience fatigue to this day that is gradually improving.
My periods after taking the secon and third vaccines would start getting further apart about two months after the COVID19 vaccine and than would last longer. Would return back to normal about three to four months after vaccine.. Last period went on for almost three weeks which is why I seeked medical attention.
Nurse administered COVID 19 vaccine (Moderna) to 17 y/o. This was discoved afer time of service clients mother was contacted 3/30/21, notified. Clients mother states client had no known reactions or side effects except a sore arm
pt recvd vax; several days became ill; to er; devel pneumonia; fever; coughing; several days of sleeplessness;
HPV4 was given to age 8 yr client. Wrong client was checked in with same first & last name but diff DOB. Patient did not have any adverse effects. No adverse reactions.
Patient was diagnosed with COVID-19 pneumonia in November 2020. Close to 3 months after his COVID19 infection, he received his first dose of COVID-19 moderna vaccine. Shortly after that he started developing weakness in his lower limbs and a work-up for spinal stenosis was initiated by his neurologist. Before his second dose of moderna COVID-19 vaccine, he was already walking with a walker. After receiving the second dose of COVID-19 moderna vaccine, he was not able to walk at all.  He was hospitalized for Guillain-Barré versus acute inflammatory demyelinating polyneuropathy. He was managed with IVIG and he underwent extensive rehab.  Five months after his hospitalization, he recovered 50% of his baseline functional level. He required one year to fully recovered his motor function.
Pt complained of itching. Arm turned red, hot, started to swell. Treated w/BENADRYL, prednisone and OMNICEF.
Headaches every day since day of injection, ocassional migraines (about one a week)
This case was reported by a physician to a sales representative and described the occurrence of swollen lymph node in an infant of unspecified gender between four and six months of age who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. The physician reported that two subjects experienced swollen lymph nodes following vaccination with Infanrix, however, subject identifiers were not provided. On an unspecified date on or before 24Oct05, the subject received a dose of Infanrix (dose number and lot number not provided. At an unspecified time after vaccination with Infanrix, on an unspecified date on or before 24Oct05, the subject experienced severe swollen lymph nodes. The subject was seen in an emergency room. The outcome of the swollen lymph nodes was not reported.
Immediately upon injection,  patient developed swelling and bruising in arm that received vaccination. Ice pack was applied and Dr. assessed patient. He ordered 50 mg diphenhydramine IM, which was administered in R deltoid at 10:19 am. BP was 120/86, respirations 18, pulse 61 and SpO2 97%.  Swelling and bruising did not worsen, nor did patient complain of any other symptoms. Patient said she felt fine. She was discharged to home at 10:30 am in stable condition, accompanied by her husband.
Shingles on leg in addition to skin rash at spot of injection. Skin rash happened a week after first vaccine and then happened again the day after the second vaccine.
In 2001, a male patient was administered a vaccine against tetanus (specific type of vaccine is unknown) in the emergency room and experienced an anaphylaxis reaction; dizziness, very short of breath. The ER staff immediately treated patient; specific treatment is unknown. Patient has recovered.
I21.4 ACUTE NON ST ELEVATION MI 3/29/2023 ACUTE NON ST ELEVATION MI GENERALIZED ANXIETY DISORDER I21.4 ACUTE NON ST ELEVATION MI 3/29/2023 ANEMIA I21.4 ACUTE NON ST ELEVATION MI 3/29/2023 CHEST PAIN